Related Experiment Video
Updated: Jul 25, 2026

Multifocal Electroretinograms
Published on: December 4, 2011
Interocular amplitude differences of the full field electroretinogram in normal subjects
Y Rotenstreich1, G A Fishman, R J Anderson
1Department of Ophthalmology and Visual Science, University of Illinois at Chicago, 1855 W. Taylor, Chicago, IL 60612, USA.
The electroretinogram (ERG) shows similar b-wave amplitude differences between eyes in healthy individuals, with medians from 8-11%. These findings aid in designing clinical trials for retinal diseases and detecting asymmetric conditions.
Area of Science:
- Ophthalmology
- Neuroscience
- Clinical Electrophysiology
Background:
- The electroretinogram (ERG) is a key diagnostic tool for retinal function.
- Understanding normal interocular variability is crucial for interpreting ERG results.
Purpose of the Study:
- To quantify the interocular amplitude response difference of the electroretinogram (ERG) in normal subjects.
- Establish normative data for ERG b-wave amplitude variations between eyes.
Main Methods:
- 79 healthy subjects underwent ERG testing following ISCEV standards.
- Recorded various ERG responses including rod, scotopic, and flicker stimuli.
- Calculated interocular percentage differences in b-wave amplitudes.
Main Results:
- Median interocular percentage differences in b-wave amplitudes ranged from 8% to 11%.
- Mean differences varied from 11% to 14%.
- 95th percentile differences ranged from 27% to 36%.
Conclusions:
- Normal individuals exhibit consistent interocular ERG b-wave amplitude differences.
- Findings support sample size calculations for monocular therapeutic trials.
- Normative data aids in detecting asymmetric retinal diseases.
More Related Videos
07:45Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition
Published on: July 21, 2020
08:38Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020